FDA approves Johnson & Johnson's Varipulse for targeted atrial fibrillation treatment, enhancing precision and safety ...

J&J is the third medtech company to gain U.S. approval for pulsed field ablation, a new atrial fibrillation treatment seeing ...

Dr. Mehran Attari, a cardiac electrophysiologist with Mercy Health, discusses a new treatment option for atrial fibrillation (AFib): pulse field ablation (PFA). Atrial fibrillation is the most common ...

The technology is integrated with company’s electroanatomical mapping system, which helps guide operators during AF ablation.

The staff at Shasta Regional Medical Center (SRMC) is celebrating their 100th Watchman heart implant procedure, which took ...

Johnson & Johnson MedTech will enter the U.S. pulsed field ablation market following an FDA green light for its Varipulse ...

Growth of the market is driven by the prevalence of atrial fibrillation cases and cardiac disorders, a rise in the number of hypertension patients, growth in the geriatric population, and increasing ...

The terms “controlled AFib” and “uncontrolled AFib” describe whether treatment strategies are effectively managing a person’s irregular heart rate. Controlled AFib is when doctors have ...

Cortex adds to Boston Scientific’s electrophysiology portfolio amid treatment shifts in the space driven by new pulsed field ...

Expanding its portfolio further into cardiovascular health, Marlborough medical device manufacturer Boston Scientific has ...

AtriCure stock rose more than 16% on news of plans to expand into pulsed field ablation, a tech that could potentially better treat AFib.

Boston Scientific ( (BSX) ) just unveiled an announcement. Boston Scientific Corporation has announced the resumption of its AVANT GUARD ...